Previous 10 | Next 10 |
The company reports an EPS beat of $0.72 in the third quarter. We look into how management has been employing its capital. We like the results as well as the underlying trend. A bullish move through a breakout above the bullish triangle (below) could be on the cards here short...
-- Provides additional operational and financial flexibility -- -- Underscores strength of forecasted earnings and operating cash flow -- TAMPA, Fla., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to ...
Pacira BioSciences (NASDAQ:PCRX) announces preliminary sales for Exparel (bupivacaine liposome injectable suspension) and iovera° for the month of November 2021. Exparel net product sales were $46.5M. Exparel average daily sales for November 2021 were 122% of November 2020. Net product s...
-- EXPAREL average daily sales for November 2021 - 122% of November 2020 – TAMPA, Fla., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported...
John Paulson’s 13F portfolio value decreased from $4.35B to $3.51B this quarter. Paulson & Company increased Perpetua Resources and DiDi Global while dropping DISH Network. The top three positions are at 55% of the portfolio. For further details see: Tracking ...
TAMPA, Fla., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Piper Sandler 33 rd Annual Virtual Healthcare Conference at 9:30 AM ET on Tuesday, November 30, 2021. Live audio of ...
CyrusOne (CONE) and CoreSite (COR) agreed to be acquired in deals valued at $15 billion and $10 billion, respectively. Data centers have been a significant area of growth over the last couple of decades. Ranked by colocation and data center revenues, CyrusOne and CoreSite are the ...
-- Adds highly complementary ZILRETTA ® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain pathway -- TAMPA, Fla. and BURLINGTON, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc...
TAMPA, Fla., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Jefferies London Healthcare Conference at 11:20 AM GMT (6:20AM ET) on Tuesday, November 16, 2021. Live audio of the even...
TAMPA, Fla., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary unaudited net product sales. EXPAREL ® (bupivacaine liposome inj...
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results after the close of the U.S. markets on Tuesday July 30, 2024. Following the release, the company will host a live conference call and webc...
-- Proposed Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment System Rule extends separate payment from ambulatory surgical centers to include the hospital outpatient environment – -- Rule implements the NOPAIN Act, signed into law as part of the Cons...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 86.1% to $0.514 on volume of 587,366,807 shares NVIDIA Corporation (NVDA) fell 1.3% to $122.67 on volume of 214,038,378 shares Tesla Inc. (TSLA) rose 10.2% to $231.26 on volume of 201,850,947 ...